santa cruz biotechnology, inc.
SCBT Logo

Willkommen!        Produkt(e) im Warenkorb.     Bestellen
 

EGFR Inhibitors

  • AG 494
    Potent inhibitor of epidermal growth factor receptor (EGFR) kinase (IC50 = 0.7 μM). Selective over ErbB2, PDGFR and insulin receptor kinase (IC50s are 42, 6 and >100 μM respectively).
    Katalog #CAS NummerSummenformelMenge
    sc-202043133550-35-3C16H12N2O310 mg/50 mg
  • AG 555
    Potent epidermal growth factor receptor (EGFR) kinase inhibitor (IC50 = 0.7 μM) that displays 50-fold and >140-fold selectivity over ErbB2 and insulin receptor kinase respectively. Induce G1 growth arrest selectively in transformed cells (IC50 values are 6.4 and 9.4 μM in HPV16-immortalized and normal keratinocytes respectively).
    Katalog #CAS NummerSummenformelMenge
    sc-203500133550-34-2C19H18N2O310 mg/50 mg
  • AG 1478 hydrochloride
    Katalog #CAS NummerSummenformelMenge
    sc-361101153436-53-4C16H14ClN3O2.HCl10 mg/50 mg
  • Tyrphostin AG 1478
    A potent and selective inhibitor of EGFR; reported to block EGF-dependent src-family kinase activation and ERK phosphorylation.
    Katalog #CAS NummerSummenformelMenge
    sc-200613175178-82-2C16H14ClN3O25 mg/25 mg
  • BIBU 1361 dihydrochloride
    Selective inhibitor of EGFR-kinase. Selectivity is exhibited over a range of other related tyrosine kinases. Blocks downstream signaling. Administration orally inhibits growth of established human xenografts in athymic mice.
    Katalog #CAS NummerSummenformelMenge
    sc-203844793726-84-8C22H27ClFN7•2HCl1 mg/10 mg
  • BIBX 1382
    Cell-permeable pyrimidopyrimidine. Potent, reversible, ATP-competitive, and highly selective inhibitor of EGFR (ErbB-1, HER-1) both in cell-free enzymatic reactions and in culture.
    Katalog #CAS NummerSummenformelMenge
    sc-202497196612-93-8C18H19ClFN7 ·2HCl ·2H2O5 mg
  • DAPH
    A tyrosine kinase inhibitor, which suppresses and reverses the formation of Aβ42 fibers in neurons.
    Katalog #CAS NummerSummenformelMenge
    sc-200698145915-58-8C20H15N3O25 mg
  • Erbstatin Analog
    Inhibitor of EGFR (epidermal growth factor receptor)-associated tyrosine kinase. Blocks EGFR-mediated cellular phenotypic changes and delays EGF-induced DNA synthesis.
    Katalog #CAS NummerSummenformelMenge
    sc-20051163177-57-1C10H10O45 mg/25 mg
  • JNJ 28871063 hydrochloride
    Potent and selective ErbB receptor family inhibitor (IC50 values are 21, 22 and 38 nM for ErbB4, EGFR and ErbB2 respectively). Displays potent growth inhibition of human cancer cell lines overexpressing ErbB2 in vitro (IC50= 60 - 168 nM). Inhibits growth of human tumor xenografts in vivo. Orally active and brain penetrant.
    Katalog #CAS NummerSummenformelMenge
    sc-204025944341-54-2C24H27CIN6O3•HCl10 mg/50 mg
  • Lavendustin A
    Inhibitor of the EGF receptor tyrosine kinase. Binds kinase on a site distinct from the ATP and peptide substrate binding sites. Suppresses VEGF-induced angiogenesis in rats.
    Katalog #CAS NummerSummenformelMenge
    sc-200539125697-92-9C21H19NO61 mg/5 mg
  • Lavendustin B
    Lavendustin B is a weak tyrosine kinase inhibitor that can be used as a negative control for lavendustin A (sc-200539).
    Katalog #CAS NummerSummenformelMenge
    sc-200595125697-91-8C21H19NO51 mg/5 mg
  • PD 153035
    An extremely potent and specific inhibitor of the tyrosine kinase activity of the epidermal growth factor receptor (EGFR).
    Katalog #CAS NummerSummenformelMenge
    sc-205909153436-54-5 (HCl salt)C16H14BrN3O21 mg
  • PD 153035 Hydrochloride
    An extremely potent inhibitor of epidermal growth factor (EGF) receptor tyrosine kinase (IC50 = 25 pM). Only inhibits other purified tyrosine kinases at micromolar or higher concentrations.
    Katalog #CAS NummerSummenformelMenge
    sc-205963153436-54-5C16H14BrN3O2 ·HCl10 mg/50 mg
  • RG-13022
    A tyrosine kinase tyrphostin. Reports indicate that it suppresses epidermal growth factor (EGF)-stimulated cancer cell proliferation in cancer cell studies.
    Katalog #CAS NummerSummenformelMenge
    sc-200591136831-48-6C16H14N2O25 mg/25 mg
  • Tyrphostin RG 14620
    Non-phenolic tyrphostin analog, which is selective for the EGF receptor and long acting. Inhibits EGF-stimulated HER14 cell proliferation as well as tumor growth in vivo.
    Katalog #CAS NummerSummenformelMenge
    sc-200593136831-49-7C14H8Cl2N25 mg/25 mg
  • Tyrphostin B44, (+) enantiomer
    Epidermal growth factor receptor (EGFR) kinase inhibitor. Slightly less active than the (-) enantiomer
    Katalog #CAS NummerSummenformelMenge
    sc-203305133550-37-5C18H16N2O35 mg
  • Tyrphostin B44, (-) enantiomer
    A potent inhibitor of epidermal growth factor receptor (EGFR) kinase (IC50 = 0.4 μM), more active than the (+) enantiomer. Selective over ErbB2.
    Katalog #CAS NummerSummenformelMenge
    sc-203711133550-32-0C18H16N2O35 mg
  • Tyrphostin 47 (RG-50864, AG-213)
    Tyrphostin 47 (RG-50864, AG-213) is a protein tyrosine kinase inhibitor particularly potent against epidermal growth factor (EGF) kinase activity.
    Katalog #CAS NummerSummenformelMenge
    sc-200543122520-86-9C10H8N2O2S5 mg/25 mg
  • Tyrphostin 51
    A potent inhibitor of EGF receptor kinase activity (IC50=0.8 µM). Inhibition is mixed competitive with ATP and substrate.
    Katalog #CAS NummerSummenformelMenge
    sc-200545122520-90-5C13H8N4O35 mg/25 mg
  • Tyrphostin AG 99
    Inhibits epidermal growth factor (EGF) receptor tyrosine kinase (IC50 = 10 µM) and EGF-dependent cell proliferation. Inhibits EGFR phosphorylation and ERK1 and ERK2 activities.
    Katalog #CAS NummerSummenformelMenge
    sc-202847118409-59-9C10H8N2O35 mg/25 mg
  • Tyrphostin AG 183
    Inhibits epidermal growth factor receptor tyrosine kinase (IC50 = 800 nM).
    Katalog #CAS NummerSummenformelMenge
    sc-202846126433-07-6C13H8N4O325 mg/5 mg